Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis
Publication in refereed journal


Times Cited
Web of Science20WOS source URL (as at 20/09/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractPatients with inflammatory arthritis have increased risk of cardiovascular diseases (CVDs) compared with the general population. Subclinical carotid atherosclerosis and increased arterial stiffness are also common in these patients, which may serve as surrogate end points for cardiovascular (CV) events in clinical trials. Although exact mechanisms are still unclear, persistent systemic inflammation in patients with inflammatory arthritis may contribute to the development of CVD. Dysregulated innate immunity pathways in these patients may also play a role in accelerating atherosclerosis. During the last decade, effective suppression of inflammation by biological disease-modifying antirheumatic drugs has improved the disease outcome dramatically in patients with inflammatory arthritis. Growing evidence suggests that antitumor necrosis factor (TNF) therapy may prevent CVD in patients with rheumatoid arthritis. Nonetheless, data on non-TNF biologics are limited. Whether anti-TNF therapy may prevent CVD in patients with spondyloarthritis also remained unclear. In this review, we summarized the effect of both anti-INF and non-TNF biologics on the CV system, including traditional CVD risk factors, endothelial function, arterial stiffness, subclinical atherosclerosis, and clinical CVD in patients with inflammatory arthritis.
All Author(s) ListShen JY, Shang Q, Tam LS
Journal nameTranslational Research, The Journal of Laboratory and Clinical Medicine
Year2016
Month1
Day1
Volume Number167
Issue Number1
PublisherELSEVIER SCIENCE INC
Pages138 - 151
ISSN1931-5244
eISSN1878-1810
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesGeneral & Internal Medicine; Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental; Research & Experimental Medicine

Last updated on 2020-21-09 at 01:25